Medicare Enrolled

Dr. Sofia Mavasheva

Internal Medicine · Trenton, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2055 KLOCKNER RD, Trenton, NJ 08690
6095868060
In practice since 2006 (20 years)
NPI: 1851345995 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mavasheva from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mavasheva? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mavasheva

Dr. Sofia Mavasheva is an internal medicine specialist in Trenton, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mavasheva performed 928 Medicare services across 711 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mavasheva received a total of $17,298 from 57 pharmaceutical and/or device companies across 1238 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mavasheva is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 49% volume in NJ $17,298 industry payments

Medicare Practice Summary

Medicare Utilization ↗
928
Medicare services
Top 49% in NJ for internal medicine
711
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~46 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
254 $45 $400
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
223 $45 $563
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
121 $48 $575
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
100 $8 $69
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
95 $33 $104
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
91 $71 $280
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
29 $62 $402
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
15 $3 $13
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,298
Total received (2018-2024)
Avg $2,471/year across 7 years
Top 4% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
1,238
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,298 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,358
2023
$1,955
2022
$2,121
2021
$3,140
2020
$2,367
2019
$2,890
2018
$2,468

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$370
AstraZeneca Pharmaceuticals LP
$368
Novo Nordisk Inc
$296
Axsome Therapeutics, Inc.
$143
Amgen Inc.
$142
IDORSIA PHARMACEUTICALS US INC
$135
GlaxoSmithKline, LLC.
$132
Boehringer Ingelheim Pharmaceuticals, Inc.
$110
PFIZER INC.
$94
Bayer Healthcare Pharmaceuticals Inc.
$85
ABBVIE INC.
$81
Astellas Pharma US Inc
$72
Takeda Pharmaceuticals U.S.A., Inc.
$70
Exact Sciences Corporation
$53
Medtronic, Inc.
$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$44
Abbott Laboratories
$42
Esperion Therapeutics, Inc.
$27
Cleerly, Inc.
$17
AGEPHA Pharma FZ LLC
$17
Sumitomo Pharma America, Inc.
$16
Top 3 companies account for 43.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,018
AstraZeneca Pharmaceuticals LP
$1,939
Amgen Inc.
$1,507
Lilly USA, LLC
$1,499
Kowa Pharmaceuticals America, Inc.
$1,368
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,316
GlaxoSmithKline, LLC.
$726
Amarin Pharma Inc.
$619
Janssen Pharmaceuticals, Inc
$588
AbbVie Inc.
$449
ABBVIE INC.
$379
SANOFI-AVENTIS U.S. LLC
$313
IDORSIA PHARMACEUTICALS US INC
$312
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$295
Takeda Pharmaceuticals U.S.A., Inc.
$290
Astellas Pharma US Inc
$290
Merck Sharp & Dohme Corporation
$286
Vanda Pharmaceuticals Inc.
$277
PFIZER INC.
$249
AbbVie, Inc.
$228
Bayer Healthcare Pharmaceuticals Inc.
$181
Nestle HealthCare Nutrition Inc.
$165
Axsome Therapeutics, Inc.
$143
Allergan Inc.
$137
Esperion Therapeutics, Inc.
$136
Allergan, Inc.
$129
ARBOR PHARMACEUTICALS, INC.
$109
Abbott Laboratories
$109
Exact Sciences Corporation
$107
Avanir Pharmaceuticals, Inc.
$102
Eisai Inc.
$100
Corium, LLC
$94
Philips Electronics North America Corporation
$87
Daiichi Sankyo Inc.
$86
Bayer HealthCare Pharmaceuticals Inc.
$71
Novartis Pharmaceuticals Corporation
$69
Paratek Pharmaceuticals, Inc.
$58
Medtronic, Inc.
$46
EISAI INC.
$44
Sanofi Pasteur Inc.
$41
Coloplast Corp
$32
Sumitomo Pharma America, Inc.
$32
Sunovion Pharmaceuticals Inc.
$31
Teva Pharmaceuticals USA, Inc.
$27
Medicure Pharma Inc.
$26
Regeneron Healthcare Solutions, Inc.
$26
Cleerly, Inc.
$17
Adhera Therapeutics, Inc.
$17
Biogen, Inc.
$17
AGEPHA Pharma FZ LLC
$17
ITI, Inc.
$16
Biohaven Pharmaceutical Holding Company Ltd.
$14
Merck Sharp & Dohme LLC
$14
Bausch Health US, LLC
$13
Hikma Pharmaceuticals USA
$13
Eyevance Pharmaceuticals LLC
$13
Currax Pharmaceuticals LLC
$12
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ADLARITY · ADVAIR · AIRSUPRA · AJOVY · ALTIS · ANORO · ANORO ELLIPTA · AREXVY · Adlarity · Aduhelm · Aimovig · Amitiza · Auvelity · BASAGLAR · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CAPLYTA · CHANTIX · CONTRAVE · CREON · Cleerly Ischemia · Cologuard Collection Kit · Creon · Dayvigo · EMGALITY · EVENITY · Edarbi · Edarbyclor · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · HETLIOZ · INJECTAFER · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LANTUS · LEQVIO · LINZESS · LODOCO · Livalo · MOTEGRITY · MOUNJARO · MOVANTIK · MYRBETRIQ · Mitigare · Movantik · Myrbetriq · NEXLETOL · NUEDEXTA · NURTEC ODT · NUZYRA · ONZETRA Xsail · Otezla · Ozempic · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRESTALIA · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QUVIVIQ · RELISTOR · RELISTOR ORAL · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tobradex ST · Tresiba · Trintellix · UBRELVY · VESICARE · VIBERZI · VRAYLAR · Vascepa · Veozah · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · ZENPEP · ZEPBOUND · ZYPITAMAG · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in NJ.

Looking for an internal medicine specialist in Trenton?
Compare internal medicine physicians in the Trenton area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
1,458
Per 100K population
380.4
County median income
$96,333
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT HAMILTON
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mavasheva is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 4% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mavasheva experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mavasheva performed 254 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mavasheva receive payments from pharmaceutical companies?
Yes. Dr. Mavasheva received a total of $17,298 from 57 companies across 1,238 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mavasheva's costs compare to other internal medicine physicians in Trenton?
Dr. Mavasheva's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mavasheva) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →